 TUCSON, Ariz., Dec. 30, 2020 GLOBE NEWSWIRE -- HTG Molecular Diagnostics, Inc. Nasdaq: HTGM HTG, a life science company whose mission is to advance precision medicine, today announced that it has received notification of the issuance of Canadian patent number 2877729 for Nuclease Protection Methods for Detection of Nucleotide Variants. 